Alaunos Therapeutics | ZIOP - Gross Profit On Sales


Alaunos Therapeutics reported $-1.13M in Gross Profit on Sales for its fiscal quarter ending in September of 2024.





Gross Profit On Sales Change Date
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Amgen USD 6.89B 415M Dec/2025
AstraZeneca USD 12.61B 225M Mar/2026
Baxter International USD 891M 314M Mar/2026
Biogen USD 1.82B 169.5M Mar/2026
Bioline Rx USD 343K 111K Sep/2025
Bristol-Myers Squibb USD 8.41B 381M Dec/2025
Celltrion KRW 46.98B 579.12B Dec/2025
Corcept Therapeutics USD 162.02M 37.56M Mar/2026
Cspc Pharmaceutical CNY 4.01B 329.18M Dec/2025
Curis USD 1.14M 8.86M Dec/2025
Deva Holding AS TRY 1.32B 235.77M Sep/2023
Dianthus Therapeutics USD 284K 112K Dec/2025
Divis Laboratories Ltd INR 16.59B 2.05B Dec/2025
Gilead Sciences USD 5.52B 791M Mar/2026
GlaxoSmithKline GBP 5.75B 429M Mar/2026
Incyte USD 1.17B 217.51M Mar/2026
Intrexon USD -297K 167K Jun/2024
Ionis Pharmaceuticals USD 243M 48M Mar/2026
J&J USD 17.24B 642M Mar/2026
Kangmei Pharma CNY 270.29M 20.26M Sep/2025
Karyopharm Therapeutics USD 32.6M 63.38M Dec/2025
Knight Therapeutics CAD 64.72M 8.91M Dec/2025
Laboratorios Farma EUR 105.28M 177.08M Jun/2025
Medical Developments International AUD 7.35M 7.37M Jun/2025
Merck USD 10.85B 2.57B Dec/2025
Neuren Pharmaceuticals AUD 6.69M 6.37M Jun/2025
Novartis USD 10.07B 184M Mar/2026
Organigram Holdings CAD 23.32M 8.52M Dec/2025
Pfizer USD 11.04B 1.24B Mar/2026
Pharma Mar EUR 39.24M 47.46M Mar/2026
PTC Therapeutics USD 232.94M 84.56M Mar/2026
Qiagen NV USD 325.27M 19.53M Dec/2025
Regeneron Pharmaceuticals USD 2.94B 363.7M Mar/2026
Roche Holding CHF 22.09B 10.04B Dec/2025
Sangamo BioSciences -2.39M 1.09M Jun/2024
Sartorius EUR 414.5M 18.3M Mar/2026
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
TG Therapeutics USD 171.41M 16.98M Mar/2026
Tilray USD 57.47M 10.16M Jun/2025
Verastem USD 14.64M 14.1M Dec/2025
Zealand Pharma A/S 68.91M 19.35M Dec/2025
Zz Pientze Pharmaceu CNY 1.16B 860.2M Mar/2026